Mesothelioma Treatment
Mesothelioma Cancer
- Causes of Mesothelioma
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
- Mesothelioma Treatment
- Innovative Mesothelioma Treatments
- Managing Mesothelioma Pain
- Nutrition Information for Mesothelioma Patients
- Specialized Mesothelioma Care
- Mesothelioma Risks
- Mesothelioma Support Groups
- Find a Mesothelioma Attorney
- Mesothelioma News
Mesothelioma Directory
An Open-Label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma
Get Help Today
Looking for help or additional information? Contact us today.| Conditions: | Mesothelioma |
| Start Date: | September 1, 2003 |
| Phase: | Phase II |
| Status: | Completed |
| NCT ID: | NCT00787410 |
| Study Type: | Interventional |
| Intervention: | Drug: ZD1839 |
| Study Design: | Allocation: Non-Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | AstraZeneca|Dr.Christopher Lee |
| Ages: | Adult|Senior |
| Enrollment: | 23 |
| Funded By: | Industry|Other |
| First Received: | November 6, 2008 |
| End Date: | April 1, 2008 |
| Last Updated: | April 22, 2009 |
| Last Verified: | April 1, 2009 |